Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-21-031096

Director acquired 1,232,910 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Manning Paul B Director 2021-07-29 Conversion +679,158 679,158 I: show line 1 in the form
Manning Paul B Director 2021-07-29 Conversion +553,752 553,752 I: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Manning Paul B Director 2021-07-29 Conversion · Series B Preferred Stock −1,669,303 0 I: show line 3 in the form
Manning Paul B Director 2021-07-29 Conversion · Series B Preferred Stock −1,361,069 0 I: show line 4 in the form
Loading xslF345X03/doc4.xml…